It can assess patients’ suitability for Amgen’s colorectal cancer drug, Vectibix. Canadian regulatory authorities approved DxS’ TheraScreen K-RAS Mutation Kit for use as a diagnostic for anti-EGFR ...
Company will work with ImClone and BMS to develop FDA-approved test for mCRC patients. DxS is to work with ImClone Systems and Bristol-Myers Squibb on the development of a companion diagnostic for the ...
The US Food and Drug Administration (FDA) has granted approval for EntroGen's CRCdx RAS Mutation Detection Kit as a companion diagnostic for Vectibix (panitumumab), a targeted therapy used in the ...
Testing for genetic mutations has long been complicated, expensive, time-consuming, and, in some parts of the world, inaccessible. Dr. Pierre Billon, an assistant professor at the University of ...
Assures 100x upgraded detection sensitivity compare to ddPCR Higher the possibility of precision medicine in the 1st and 2nd stages of cancer patients SEOUL, South Korea--(BUSINESS WIRE)--GENECAST, ...
Transgenomic, Inc. announced that it is launching its next generation SURVEYOR Mutation Detection Kits for universal primer fluorescent capillary electrophoresis. The kits are designed to detect ...
Researchers at the University of Trento have developed a CRISPR-based adenine base editing therapy that repaired the ...
Mutation Detection Kits in Genome Editing Market · GlobeNewswire Inc. Dublin, Oct. 14, 2025 (GLOBE NEWSWIRE) -- The "Mutation Detection Kits in Genome Editing Market Report 2025" has been added to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results